Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 92,384,072
  • Shares Outstanding, K 1,100,990
  • Annual Sales, $ 21,222 M
  • Annual Income, $ 2,738 M
  • 36-Month Beta 0.34
  • Price/Sales 4.32
  • Price/Cash Flow 17.58
  • Price/Book 6.47

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.05 +7.51%
on 08/23/17
84.03 -0.14%
on 09/22/17
+5.65 (+7.22%)
since 08/22/17
3-Month
76.89 +9.13%
on 08/21/17
85.53 -1.89%
on 07/24/17
-0.40 (-0.47%)
since 06/22/17
52-Week
64.18 +30.74%
on 11/23/16
86.72 -3.24%
on 04/05/17
+2.62 (+3.22%)
since 09/22/16

Most Recent Stories

More News
European Diabetes Insulin Pen Market Outlook 2022: Top 5 Countries - Key Players are Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford & Ypsomed

DUBLIN, September 22, 2017 /PRNewswire/ --

LLY : 83.91 (+0.70%)
European Diabetes Insulin Pen Market Outlook 2022: Top 5 Countries - Key Players are Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford & Ypsomed

The "Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017 - 2022" report has been added to Research and Markets' offering.

LLY : 83.91 (+0.70%)
Drug Makers Stocks on Investors' Radar -- Alliqua BioMedical, Immune Pharma, Eli Lilly, and Merck

If you want a Stock Review on ALQA, IMNP, LLY, or MRK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Thursday, September 22, 2017, US markets...

IMNP : 1.15 (+2.68%)
ALQA : 0.42 (unch)
MRK : 65.13 (-0.72%)
LLY : 83.91 (+0.70%)
Lilly/Incyte's Baricitinib Meets Endpoint in Eczema Study

Eli Lilly and Company (LLY) and partner Incyte announced that baricitinib met its primary endpoint in a phase II study in people with moderate-to-severe atopic dermatitis.

LLY : 83.91 (+0.70%)
INCY : 110.85 (-3.65%)
REGN : 432.72 (-0.17%)
SNY : 50.34 (+0.78%)
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO

Key highlights this week include Teva's (TEVA) CEO announcement and the FDA approval of the first cancer biosimilar.

ACHN : 4.11 (+0.24%)
LLY : 83.91 (+0.70%)
AGN : 204.65 (+0.98%)
TEVA : 17.19 (+0.23%)
PFE : 35.96 (-0.03%)
GSK : 40.58 (+0.62%)
BMY : 63.36 (+0.05%)
Asia shares fall after North Korea's latest missile launch

HONG KONG (AP) — Asian stocks were mostly lower Friday after North Korea fired off another missile over Japan, ratcheting up geopolitical tensions and denting investor sentiment.

MCK : 154.01 (+0.94%)
CVX : 117.29 (+0.70%)
LLY : 83.91 (+0.70%)
UTX : 115.01 (+0.45%)
EQT : 64.26 (+0.66%)
PFE : 35.96 (-0.03%)
BA : 256.45 (+0.16%)
4 Biotech Stocks That Show Promise on Sustainable Growth

Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy...

SGMO : 13.75 (-3.85%)
HSKA : 89.36 (-0.13%)
CORT : 18.20 (+3.94%)
LLY : 83.91 (+0.70%)
HLUYY : 60.1180 (+2.89%)
GILD : 83.27 (+0.79%)
KITE : 179.30 (-0.04%)
ALXN : 142.82 (-0.07%)
Eli Lilly Partnering Deals and Alliances 2010 to 2017

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.

LLY : 83.91 (+0.70%)
Baricitinib Meets Primary Endpoint in Phase 2 Study of Patients with Moderate-to-Severe Atopic Dermatitis

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced new safety and efficacy data from a Phase 2 study of baricitinib in people with moderate-to-severe atopic dermatitis...

LLY : 83.91 (+0.70%)
INCY : 110.85 (-3.65%)
Pharma, Biotech Clinical Trial Leaders to Convene for 3rd Annual DrugDev Summit to Promote Collaboration, Technology Innovation, Engaged Sites, and More Informed Patients

DrugDev, a QuintilesIMS company, will gather the most innovative minds in pharma and biotech at the third annual DrugDev Summit, November 7-8, 2017 in Philadelphia, PA. The DrugDev Summit is a two-day...

MRK : 65.13 (-0.72%)
LLY : 83.91 (+0.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research...

See More

Support & Resistance

2nd Resistance Point 84.85
1st Resistance Point 84.38
Last Price 83.91
1st Support Level 83.09
2nd Support Level 82.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.